IP Library Granted Patent US 10,201,350
Granted Patent B2
US 10,201,350 · App. 12/628,623 · Granted Feb 12, 2019

Inflatable implant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,201,350
App. No.
12/628,623
Granted
Feb 12, 2019
Kind
B2
Abstract

Described is an inflatable implant suitable for placement in the human body and left there for an indeterminate and potentially lengthy period of time. The implant is one that has a low profile when introduced into the body and a larger profile when it is inflated with one or more filler materials. Depending upon design and use choices the delivered implant may be removable and adjustable in situ in size, position, location, form, and rigidity. Indeed, in some variations, the design of the implant may be such that it may be removed at a potentially fairly lengthy time after implantation. The implant includes at least one bladder wall that generally is at least partially non-elastic (or unexpandable) after the preselected size is reached. The bladder wall will define at least one fillable volume and may form more than one independent fillable volumes. The bladder wall, in some variations, may be partially elastic or expandable to permit adjustment of implant size or configuration after or during delivery. The implant may be used as a supporting structure in a variety of differing body tissues and structures, e.g., in the spine or as a prosthetic in plastic surgery. The implant may also be used in conjunction with other components (often having a springed bias) as a source of movement in controlling the opening of a lumen or duct, that is to say, as a type of on-off valve or as a controlled flow valve. The implant may be used as an occludant within, or adjacent to, a variety of natural or abnormal anatomical body openings, e.g., vascular and genital lumina, aneurysms, ducts, septal defects, fistulae, esophagus, etc. The wall and filler material may be selected to deliver treatment materials the locale of the implant site or to remove amounts of harmful materials from such a region. The implant may, with an appropriate filler material or bladder wall material, be used in cooperation with an appropriate radio frequency (RF) source to cause the increase of a localized internal temperature and a resulting tissue change such as coagulation, ablation, or the like. Methods of using the implant are also described.

Claims (29)

1. An inflatable, expandable implant suitable for implantation in a vascular aneurysm within a human body, comprising:

a bladder comprising a bladder wall consisting essentially of non-elastic material; and

a polymerizable filler material comprising a poly(ethylene glycol) material;

wherein said bladder wall defines a volume for enclosing of the polymerizable filler material therein between,

wherein the polymerizable filler material is adapted to cure to a viscoelastic solid or a viscoelastic liquid within the bladder volume,

wherein said bladder wall has at least one bladder wall opening for introduction of the polymerizable filler material, and at least one closure for said at least one bladder wall opening for maintaining the polymerizable filler material within the volume after introduction of the polymerizable filler material into the volume,

wherein the bladder wall is expandable to an expanded shape upon introduction of the polymerizable filler material into the volume,

wherein at least a portion of the bladder wall is in apposition, on a side wall opposite the volume, to an elastic woven fabric layer,

wherein said woven layer is not disposed within said bladder volume, and

wherein the bladder wall maintains its expanded shape after the polymerizable filler material is cured in situ to provide a supporting structure for the vascular aneurysm.

2. The implant of claim 1 wherein the non-elastic material is selected from the group consisting of polyethylene terephthalate, polyvinylchloride, polyurethanes, polyolefins, polyamides, and fluoropolymers.

3. The implant of claim 1 wherein the non-elastic material is selected from the group consisting of polytetrafluoroethylene, poly(ethylene-chlorofluoroethylene), poly(fluorinated ethylene propylene), polyperfluoroalkoxy, polychlorotrifluoroethylene, polyvinylfluoride, polyvinylidenefluoride, and expanded polytetrafluoroethylene.

4. The implant of claim 1 wherein the polymerizable filler material comprises a copolymer of a first material being said poly(ethylene glycol) material and a second material having a strong nucleophile selected from the group consisting of a thiol or a group containing a thiol.

5. The implant of claim 1 further comprising a therapeutic substance disposed within the volume of the bladder wall.

6. The implant of claim 1 further comprising a radiopaque material disposed within the volume of the bladder wall.

7. The implant of claim 6 wherein the radiopaque material is selected from the group consisting of barium sulfate, bismuth trioxide, bismuth carbonate, a powdered metal and combinations thereof.

8. The implant of claim 7 wherein the powdered metal is selected from the group consisting of tungsten, tantalum, gold, ruthenium, rhodium, osmium, iridium, palladium, platinum, rhenium and combinations thereof.

9. The implant of claim 6 wherein the radiopaque material comprises a fluid radiopaque material.

10. The implant of claim 9 wherein the fluid radiopaque material is selected from the group consisting of iopromide, metrizamide and combinations thereof.

11. An inflatable, expandable implant suitable for implantation in a vascular aneurysm within a human body, comprising:

a bladder comprising a bladder wall consisting essentially of polyurethane material; and

a polymerizable filler material comprising a poly(ethylene glycol) material;

wherein said bladder wall defines a volume for enclosing of the polymerizable filler material therein between,

wherein the polymerizable filler material is adapted to cure to a viscoelastic solid or a viscoelastic liquid within the bladder volume,

wherein said bladder wall has at least one bladder wall opening for introduction of the polymerizable filler material, and at least one closure for said at least one bladder wall opening for maintaining the polymerizable filler material within the volume after introduction of the polymerizable filler material into the volume,

wherein the bladder wall is expandable to an expanded shape upon introduction of the polymerizable filler material into the volume,

wherein at least a portion of the bladder wall is in apposition, on a side wall opposite the volume, to a woven fabric layer,

wherein said woven layer is not disposed within said bladder volume, and

wherein the bladder wall maintains its expanded shape after the polymerizable filler material is cured in situ to provide a supporting structure for the vascular aneurysm.

Assignments (10)
SECURITY INTEREST Recorded Apr 1, 2021
From: TRIVASCULAR, INC.
To: SILICON VALLEY BANK
Reel/Frame 055794/0938 →
SECURITY INTEREST Recorded Oct 2, 2020
From: ENDOLOGIX LLC (F/K/A ENDOLOGIX, INC.); NELLIX, INC.; TRIVASCULAR TECHNOLOGIES, INC.; TRIVASCULAR, INC.; TRIVASCULAR CANADA, LLC
To: DEERFIELD PRIVATE DESIGN FUND IV, L.P.
Reel/Frame 053971/0052 →
CHANGE OF NAME Recorded Oct 2, 2020
From: ENDOLOGIX, INC.
To: ENDOLOGIX LLC
Reel/Frame 053971/0135 →
SECURITY INTEREST Recorded Aug 10, 2018
From: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
To: DEERFIELD PRIVATE DESIGN FUND IV, L.P., AS AGENT
Reel/Frame 046772/0933 →
SECURITY INTEREST Recorded Aug 10, 2018
From: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
To: DEERFIELD ELGX REVOLVER, LLC, AS AGENT
Reel/Frame 046762/0169 →
RELEASE OF SECURITY INTEREST Recorded Jan 12, 2018
From: DEERFIELD ELGX REVOLVER, LLC, AS AGENT
To: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
Reel/Frame 045059/0971 →
SECURITY INTEREST Recorded Apr 3, 2017
From: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
To: DEERFIELD ELGX REVOLVER, LLC, AS AGENT
Reel/Frame 042146/0454 →
SECURITY INTEREST Recorded Apr 3, 2017
From: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
To: DEERFIELD PRIVATE DESIGN FUND IV, L.P., AS AGENT
Reel/Frame 042141/0354 →
RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Feb 4, 2016
From: CAPITAL ROYALTY PARTNERS II L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: TRIVASCULAR, INC.
Reel/Frame 037701/0097 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Oct 12, 2012
From: TRIVASCULAR, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 029117/0323 →